Comparative effects of neutron irradiation and X irradiation on the embryonic development of the rat.

Radiat Res

Research and Development Division, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939.

Published: February 1994

Our aim was to compare the dose-response relationship for the embryotoxic effects of 0.43 MeV neutrons with those of 240 kVp X rays after in utero exposures during early organogenesis in the rat. At 9.5 days after conception, pregnant rats were exposed to 0.025 to 0.35 Gy 0.43 MeV neutrons at a dose rate of 0.04 to 0.07 Gy/h. Comparable biological effects were produced using 0.50 to 2.05 Gy 240 kVp X rays. Neutron irradiation produced a greater proportion of offspring with very low body weight than with malformations when compared to X rays. There were no embryotoxic effects observed at neutron exposures of 0.025, 0.049, 0.079, 0.10, 0.15 and 0.20 Gy or X-ray exposures of 0.50 and 0.96 Gy. Taken together, the results suggest that the mechanisms by which neutron irradiation affects embryonic development may, in part, be both quantitatively and qualitatively different from those by which X irradiation affects development. These results support the generalization that the embryo exhibits a nonlinear response to increasing doses of ionizing radiations during the period of early organogenesis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

neutron irradiation
12
irradiation embryonic
8
embryonic development
8
embryotoxic effects
8
043 mev
8
mev neutrons
8
240 kvp
8
kvp rays
8
early organogenesis
8
irradiation
5

Similar Publications

Heterogeneous head phantom for validating treatment planning system in boron neutron capture therapy.

Appl Radiat Isot

January 2025

Institute of Nuclear Engineering and Science, National Tsing Hua University, 101, Sec. 2, Kuang-Fu Road, Hsinchu, 30013, Taiwan; Nuclear Science and Technology Development Center, National Tsing Hua University, 101, Sec. 2, Kuang-Fu Road, Hsinchu, 30013, Taiwan. Electronic address:

In clinical boron neutron capture therapy (BNCT), the distribution of dose to a heterogeneous medium that is predicted by a treatment planning system (TPS) should be experimentally validated. A head phantom specifically developed for this purpose is described and demonstrated herein. The cylindrical phantom exhibits distinct regions made from four materials (polymethyl methacrylate, calcium phosphate, air, and boric acid) to approximate a head structure with explicitly defined skin, skull, and brain tissue with a cavity and tumor within.

View Article and Find Full Text PDF

Safe storage of fresh and irradiated fuel is ensured by solving the problem of photon emission protection. The neutron component is usually not taken into account due to its low intensity. However, for the new VVER-1200 fuel, the neutron component consideration is a mandatory procedure for radiation safety.

View Article and Find Full Text PDF

Metal halide perovskite (MHP) solar cells are promising aerospace power sources given their potential as inexpensive, lightweight, and resilient solar electricity generators. Herein, the intrinsic radiation tolerance of unencapsulated methylammonium lead iodide/chloride (CHNHPbICl) films was isolated. Spatially resolved photoluminescence (PL) spectroscopy and confocal microscopy revealed the fundamental defect physics through optical changes as films were irradiated with 4.

View Article and Find Full Text PDF

Transcriptome analysis of human oral squamous cancer SAS cells as an early response after boron neutron capture therapy.

Appl Radiat Isot

January 2025

Department of Molecular and Genomic Biomedicine, Nagasaki University Graduate School of Biomedical Sciences, 852-8523, Nagasaki, Japan; Central Radioisotope Division, National Cancer Center Research Institute, 104-0045, Tokyo, Japan; Division of BNCT, EPOC, National Cancer Center, Tokyo, Japan; Division of Chemotherapy and Clinical Cancer Research, National Cancer Center Research Institute, 104-0045, Tokyo, Japan. Electronic address:

Boron neutron capture therapy (BNCT) is based on nuclear reactions between thermal neutron and boron-10 preferentially distributed in the cancer cells. B-boronophenylalanine (BPA) is the approved drug for treatment of oral cancers for BNCT. However, the predictive biomarkers to evaluate therapeutic efficacy and side-effects have not been clarified yet.

View Article and Find Full Text PDF

Multi-layer shielding optimization of a high activity Am-Be mixed field irradiation facility.

Appl Radiat Isot

March 2025

Experimental Nuclear Physics Department, Nuclear Research Centre, Egyptian Atomic Energy Authority, Egypt; Cyclotron Facility, Egyptian Atomic Energy Authority, Egypt.

Neutron and gamma-ray shielding design for a 30Ci (1.11TBq) Am-Be irradiation facility is studied using MCNP5 Monte Carlo simulation code. The study focuses on the optimization of the shielding layers of the previously planned neutron irradiation facility.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!